Page last updated: 2024-09-04
perifosine and xl765
perifosine has been researched along with xl765 in 1 studies
Compound Research Comparison
| Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (xl765) | Trials (xl765) | Recent Studies (post-2010) (xl765) |
|---|---|---|---|---|---|
| 245 | 31 | 140 | 33 | 10 | 32 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boratyn, E; Durbas, M; Horwacik, I; Kamycka, E; Rokita, H | 1 |
Other Studies
1 other study(ies) available for perifosine and xl765
| Article | Year |
|---|---|
GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Synergism; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quinolines; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases | 2015 |